CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionProfit margin is -36.9%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)
- FinancialsAltman Z-Score 2.49: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.14BCNY618.67M · vs all stocks (USD)
Revenue (TTM)
657.15MCNY98.13M · vs all stocks (USD)
Profit Margin
-36.87%vs Medical Instruments & Supplies peers
Beta
0.3740xvs all stocks
52-Week Change
-31.04%vs all stocks
Market Capitalization
4.14BCNY618.67M · vs all stocks (USD)
Enterprise Value
4.46BCNY666.06M · vs all stocks (USD)
Forward P/E
15.24xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.21xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.67xvs Medical Instruments & Supplies peers
Enterprise to Revenue
6.79xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-113.60xvs Medical Instruments & Supplies peers
Gross Margin
38.80%vs Medical Instruments & Supplies peers
Profit Margin
-36.87%vs Medical Instruments & Supplies peers
Operating Margin
-10.66%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-3.58%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-18.44%vs Medical Instruments & Supplies peers
Revenue (TTM)
657.15MCNY98.13M · vs all stocks (USD)
Revenue per Share (TTM)
1.30CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-5.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
170.35MCNY25.44M · vs all stocks (USD)
EBITDA (TTM)
-39.26MCNY-5.86M · vs all stocks (USD)
Net Income (TTM)
-242.31MCNY-36.18M · vs all stocks (USD)
Operating Cash Flow (TTM)
38.31MCNY5.72M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
13.49MCNY2.01M · vs all stocks (USD)
5-Year Average Dividend Yield
0.27%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
86.13MCNYFY2025 · Dec 31, 2025Revenue
685.96MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
472.97MCNYFY2025 · Dec 31, 2025Gross Profit
212.99MCNYFY2025 · Dec 31, 2025Operating Income
-94.32MCNY-14.08M · vs all stocks (USD)
Pre-tax Income
-233.95MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.87MCNYFY2025 · Dec 31, 2025Net Income
-246.82MCNYFY2025 · Dec 31, 2025EBIT
-213.28MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-10.88MCNYFY2025 · Dec 31, 2025Research & Development
47.92MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
154.54MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.52MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
20.67MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.4700CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.4700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
522.52MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
522.52MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-246.82MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-209.91MCNYFY2025 · Dec 31, 2025Free Cash Flow
-255.71MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
211.80MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-246.82MCNYFY2025 · Dec 31, 2025Other Non-cash Items
32.44MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-26.92MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
31.40MCNYFY2025 · Dec 31, 2025Capital Expenditures
-45.80MCNYFY2025 · Dec 31, 2025Purchase of Investments
-312.66MCNYFY2025 · Dec 31, 2025Sale of Investments
150.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-208.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
634.76MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-447.15MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-19.76MCNYFY2025 · Dec 31, 2025Other Financing Charges
-34.25MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
133.61MCNYFY2025 · Dec 31, 2025Shares Outstanding
525.09MSharesUpdated Sep 22, 2026Float Shares
284.89MSharesUpdated Sep 22, 2026% Held by Insiders
44.03%vs all stocks
% Held by Institutions
1.40%vs all stocks
Total Cash (MRQ)
400.12MCNY59.75M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7790CNYUpdated Sep 22, 2026Total Debt (MRQ)
786.16MCNY117.40M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.6702xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.9390xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
2.12CNYUpdated Sep 22, 2026Total Assets
2.31BCNY344.90M · vs all stocks (USD)
Total Current Assets
585.29MCNYFY2025 · Dec 31, 2025Total Liabilities
1.00BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.72BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
369.67MCNYFY2025 · Dec 31, 2025Total Current Liabilities
634.42MCNYFY2025 · Dec 31, 2025Cash
281.97MCNYFY2025 · Dec 31, 2025Cash Equivalents
13.31MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
295.28MCNYFY2025 · Dec 31, 2025Accounts Receivable
115.82MCNYFY2025 · Dec 31, 2025Inventory
112.69MCNYFY2025 · Dec 31, 2025Accounts Payable
128.49MCNYFY2025 · Dec 31, 2025Short-term Debt
402.96MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.84MCNYFY2025 · Dec 31, 2025Long-term Debt
304.10MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
60.11MCNYFY2025 · Dec 31, 2025Common Stock (Book)
525.09MCNYFY2025 · Dec 31, 2025Retained Earnings
73.89MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.31BCNY194.96M · vs all stocks (USD)
Treasury Stock
21.99MCNYFY2025 · Dec 31, 202552-Week Low
6.95CNYUpdated Sep 22, 202652-Week High
12.45CNYUpdated Sep 22, 202652-Week Change
-31.04%vs all stocks
Beta
0.3740xvs all stocks
50-Day MA
8.35CNYUpdated Sep 22, 2026200-Day MA
8.98CNYUpdated Sep 22, 2026Avg 10-Day Volume
9.73MSharesUpdated Sep 22, 2026Avg 30-Day Volume
14.53MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
-0.4700CNYUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -36.9%, lower than 95% of its Medical Instruments & Supplies peers (median 8.7%)Significant
Profit margin: -0.37Industry median: 0.09Industry P5: -0.21Peers compared: 62.00
Financial Health
Altman Z-Score 2.49: grey zoneSignificant
Altman Z-Score: 2.49
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Gree Electric Appliances, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Tongling Zhongfa Trinity Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Array Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tieliu Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hamaton Automotive Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Feymer Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Bichamp Cutting Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Suzhou Xingye Materials Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sung Kwang Bend Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Weebit Nano Limited
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Companies that share active interpretations — structural patterns currently present in both stocks.
National Silicon Industry Group Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Share With Multi-Year Earnings Decrease
Ramaco Resources Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Share With Multi-Year Earnings Decrease
Beijing Yjk Building Software Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDown-Close Share With Multi-Year Earnings Decrease